Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Hepatitis B

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Hepatitis B in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, M1
Ye, Y1
Wang, F1
Zhu, J1
Zhao, Q1
Zheng, Y1
Gu, Y1
Xie, C1
Huang, Z1
Tai, Q1
Chong, Y1
Gao, Z1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Hepatitis B

ArticleYear
Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure.
    Journal of translational medicine, 2014, Mar-06, Volume: 12

    Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Count; Cell Separation; Dinoprostone;

2014